Navigant and HFMA publish a survey regarding revenue cycle management, a very important topic for health care providers.
Read More
We think generic drugs always contribute to lower spending, but research in the Annals of Internal Medicine finds that generic drugs with a monopoly or in a duopoly have very large price increases, while those in more competitive markets see price declines.
http://annals.org/aim/article/2636750/high-generic-drug-prices-market-competition-retrospective-cohort-studyAltarum releases its first quarter 2017 health spending trend report.
Read More
A new AHRQ Statistical Brief describes where consumers get their usual medical care.
Read More
Enjoy the holiday and spend a few minutes contemplating what we celebrate.
Read More
Large drug company Roche (no relation, unfortunately) is playing the sugar daddy and sweetly acquiring diabetes logging app mySugr, giving its shareholders a rich payday. mySugr said its goal was to make diabetes suck less; I doubt the company did anything meaningful in that regard, but did get its shareholders a less sucky day.
http://medcitynews.com/2017/06/roche-acquires-mysugr/?_hsenc=p2ANqtz--L5_4mspEemPxPhKWLS20DJbg7lbxF0SdeBuRLJJrH_DcIK3RomlzHTU3M7hVEh5WnDV0h-eS9mh7LSqpsUQ0zP4-1m1g0XVyBf6JAQSTmNEfbGrs&_hsmi=53765476&rf=1A lot of nonsense is being tossed around about attempts to change the current federal health "reform" law.
Read More
Denied claims cost hospitals in lost revenue and rework, according to a study from Change Healthcare.
Read More
